A clinical trial testing two drugs against the Bundibugyo ebolavirus, which is driving a fast-moving outbreak in Central ...
Point-of-care testing is disrupting global diagnostics, creating opportunities for companies such as Lumos Diagnostics ...
A study of the Galleri multicancer early detection test did not meet its primary endpoint of reducing the detection of ...
SkylineDX’s test stratifies cutaneous melanoma patients into metastatic risk categories to inform treatment decisions.
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
The clearance gives New York clinicians access to the Haystack MRD assay, which detects residual or recurring solid tumour ...
Samsung and Alcedis will explore how Galaxy Watch biometric data can support clinical trials, digital endpoints, and drug ...
Apollo Cancer Centres launches Shield™ Multi-Cancer Detection, a blood-based test that can detect signs of multiple cancers ...
Large language models (LLMs) are rapidly being integrated into clinical workflows, supporting tasks such as diagnosis ...
Findings from 14 studies involving more than 8,000 patients show Prolaris adds insight beyond conventional clinical risk categories ...
Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies for trial enrollment and precisely evaluate treatment response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results